Telsey Advisory Group Reiterates “Outperform” Rating for Bath & Body Works (NYSE:BBWI)

Telsey Advisory Group reissued their outperform rating on shares of Bath & Body Works (NYSE:BBWI) in a report released on Thursday morning,Benzinga reports. Telsey Advisory Group currently has a $43.00 target price on the stock.

BBWI has been the topic of several other research reports. Morgan Stanley lowered their price target on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research report on Thursday, November 21st. Deutsche Bank Aktiengesellschaft upped their target price on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Barclays upped their target price on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a report on Tuesday, November 26th. Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Finally, JPMorgan Chase & Co. raised shares of Bath & Body Works from a “neutral” rating to an “overweight” rating and upped their target price for the stock from $41.00 to $47.00 in a report on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $43.63.

Bath & Body Works Stock Performance

Bath & Body Works stock opened at $38.51 on Thursday. The stock has a market cap of $8.34 billion, a PE ratio of 9.39, a price-to-earnings-growth ratio of 0.96 and a beta of 1.83. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The firm’s 50-day simple moving average is $37.70 and its 200 day simple moving average is $33.87.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.46 by $0.03. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.48 earnings per share. As a group, analysts predict that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 21st will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.08%. Bath & Body Works’s payout ratio is currently 19.51%.

Institutional Investors Weigh In On Bath & Body Works

Institutional investors have recently added to or reduced their stakes in the company. Golden State Wealth Management LLC bought a new position in Bath & Body Works in the 4th quarter worth $26,000. SRS Capital Advisors Inc. raised its holdings in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after purchasing an additional 329 shares in the last quarter. True Wealth Design LLC raised its holdings in Bath & Body Works by 5,270.0% in the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after purchasing an additional 1,054 shares in the last quarter. UMB Bank n.a. raised its holdings in Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after purchasing an additional 335 shares in the last quarter. Finally, Lindbrook Capital LLC raised its holdings in Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock worth $37,000 after purchasing an additional 431 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.